Young Innovations consistently adheres to a three-pronged strategy for growth - acquire, enhance and improve, which provides the foundation for continuing success.
-
History
Young Innovations was founded around 1900 and was a pioneer of US manufactured dental products. In modern history, Young Innovations was built through the 1990’s and early 2000’s through a series of mergers and acquisitions in a variety of dental segments. Young went public in 1997 and traded on the NASDAQ stock exchange under the ticker YDNT for over 15 years. In 2013, Young was acquired by Linden Capital Partners, a healthcare-focused private equity investment firm. In 2017, Linden Capital sold a majority interest to The Jordan Company, LP (“TJC”). TJC is a leading investment firm with a long history of partnering with management teams to help them build their businesses through a combination of strategic investments to drive organic growth and acquisitions.
Young Innovations continues to build on its rich legacy of manufacturing and supplying high-quality products designed to improve the clinical experience for dental professionals and patients. We believe in creating smiles and creating possibilities, and will continue to make history doing so!
What is Healthcare transparency
Healthcare transparency helps customers know the cost of a covered item or service before receiving care. Beginning July 1, 2022, group health plans will begin posting pricing information for covered items and services.
UnitedHealthcare is committed to supporting the Transparency in Coverage Rule by making Machine-Readable Files (MRF) available for UnitedHealthcare customers. UnitedHealthcare creates and publishes the Machine-Readable Files (MRF) on behalf of Young Innovations, Inc. Please click on the URL provided to view the Transparency in Coverage with UnitedHealthcare:
-
Strategy
Young Innovations strategy of Focused Excellence is designed to drive significant growth and opportunity, which delivers significant value for our stakeholders, including clinicians, business partners, employees and patients. At our core, we focus on high-quality and efficient manufacturing of branded clinical supplies and equipment. We seek out opportunities to grow our portfolio of brands and products through organic growth and acquisitions.
To achieve the greatest strategic focus, our business is separated into two divisions: manufactured products which are sold through dental distributors and products supplied directly to dental professionals. We also focus on partnering with other dental companies to provide them with products and solutions to support their growth. We are a lean, matrixed organization with dedicated employees with significant expertise and tenure.
We apply rigorous focus to all our activities, carefully selecting where best to spend our time. We execute aggressively on our stated goals and objectives across our business, and hold ourselves accountable to measurable results. It is through this Focused Excellence approach that we can continue creating smiles and creating possibilities.
-
Leadership
STEVE CLAREEN
VP-GM, Oral Surgery
KENNETH SEROTA
Chief Executive Officer
MICHAEL SHERMAN
Chief Financial Officer
BRIAN WERNER
Chief Quality & Operations Officer
MARK PELUSE
VP of Global HR & Legal
DAN GARRICK
VP of Corporate Development
JOHN FRYMARK
VP, Product, Marketing, and Analytics
BRANDON ARSENAULT
VP of Sales, Young Specialties
-
Board
John Jordan II
David Butler
John Straus
Barry Gallup, Jr.
Kenneth Serota
Michael Farah
Bill Jellison
Gerard Moufflet
Mark Burggraaff